Eli Lilly inks partnership deal with Cipla for key diabetes drugs

INDIA – The Indian arm of North American drugmaker Eli Lilly has announced a strategic partnership with Indian pharmaceutical Cipla, allowing the latter to sell, promote, and distribute two of Lilly’s diabetes products, Humalog and Trucility, in India. The collaboration is subject to regulatory approval. Lilly also noted that it will maintain its existing operation model for its other products, with the main idea being to leverage Cipla’s strong local footprint. Cipla, at its end, would leverage its capabilities and robust distribution strengths to engage healthcare professionals and expand access…

Read More